Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study

Judith van Loon; Claudia Offermann; Michel Ollers; Wouter van Elmpt; Erik Vegt; Ali Rahmy; Anne-Marie C. Dingemans; Philippe Lambin; Dirk De Ruysscher

doi:10.1016/j.radonc.2011.03.014

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study

Judith van Loon, Claudia Offermann, Michel Ollers, Wouter van Elmpt, Erik Vegt, Ali Rahmy, Anne-Marie C. Dingemans, Philippe Lambin, Dirk De Ruysscher

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	172-175
Journal	Radiotherapy and Oncology
Volume	99
Issue number	2
DOIs	https://doi.org/10.1016/j.radonc.2011.03.014
Publication status	Published - May 2011

Keywords

Outcome prediction
Small cell lung cancer
SCLC
PET
Metabolic response

Access to Document

10.1016/j.radonc.2011.03.014

Cite this

van Loon, J., Offermann, C., Ollers, M., van Elmpt, W., Vegt, E., Rahmy, A., Dingemans, A-M. C., Lambin, P., & De Ruysscher, D. (2011). Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study. Radiotherapy and Oncology, 99(2), 172-175. https://doi.org/10.1016/j.radonc.2011.03.014

van Loon, Judith ; Offermann, Claudia ; Ollers, Michel ; van Elmpt, Wouter ; Vegt, Erik ; Rahmy, Ali ; Dingemans, Anne-Marie C. ; Lambin, Philippe ; De Ruysscher, Dirk. / Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study. In: Radiotherapy and Oncology. 2011 ; Vol. 99, No. 2. pp. 172-175.

@article{bec6a9129bdf4e25ac1b9e430e1a9df5,

title = "Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study",

keywords = "Outcome prediction, Small cell lung cancer, SCLC, PET, Metabolic response",

author = "{van Loon}, Judith and Claudia Offermann and Michel Ollers and {van Elmpt}, Wouter and Erik Vegt and Ali Rahmy and Dingemans, {Anne-Marie C.} and Philippe Lambin and {De Ruysscher}, Dirk",

year = "2011",

month = may,

doi = "10.1016/j.radonc.2011.03.014",

language = "English",

volume = "99",

pages = "172--175",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

van Loon, J, Offermann, C, Ollers, M, van Elmpt, W, Vegt, E, Rahmy, A, Dingemans, A-MC , Lambin, P & De Ruysscher, D 2011, 'Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study', Radiotherapy and Oncology, vol. 99, no. 2, pp. 172-175. https://doi.org/10.1016/j.radonc.2011.03.014

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study. / van Loon, Judith; Offermann, Claudia; Ollers, Michel; van Elmpt, Wouter; Vegt, Erik; Rahmy, Ali; Dingemans, Anne-Marie C.; Lambin, Philippe ; De Ruysscher, Dirk.

In: Radiotherapy and Oncology, Vol. 99, No. 2, 05.2011, p. 172-175.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study

AU - van Loon, Judith

AU - Offermann, Claudia

AU - Ollers, Michel

AU - van Elmpt, Wouter

AU - Vegt, Erik

AU - Rahmy, Ali

AU - Dingemans, Anne-Marie C.

AU - Lambin, Philippe

AU - De Ruysscher, Dirk

PY - 2011/5

Y1 - 2011/5

KW - Outcome prediction

KW - Small cell lung cancer

KW - SCLC

KW - PET

KW - Metabolic response

U2 - 10.1016/j.radonc.2011.03.014

DO - 10.1016/j.radonc.2011.03.014

M3 - Article

C2 - 21571382

VL - 99

SP - 172

EP - 175

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -